Search clinical trials for: 0.5g SRT2104

Total 1274 results

Sirtris, a GSK Company
GlaxoSmithKline

Completed

A Clinical Study to Assess the Effect of Food and Gender on the Pharmacokinetics of SRT2104 Administered as an Oral Suspension or Capsule Formulation to Normal Healthy Volunteers

Diabetes Mellitus, Type 2

United Kingdom
GlaxoSmithKline

Completed

Clinical Study to Assess the Effects of SRT2104 and Prednisolone on Biomarkers in Blood in Healthy Volunteers

Pulmonary Disease, Chronic Obstructive

United Kingdom
Sirtris, a GSK Company

Completed

A Study to Assess the Relative Bioavailability of New Oral Formulations of SRT2104 in Healthy Male Volunteers

Psoriasis

United States
GlaxoSmithKline

Completed

Effect of SRT2104 on Endotoxin-induced Inflammation

Sepsis

Netherlands
Sirtris, a GSK Company
GlaxoSmithKline

Completed

A Clinical Study to Evaluate the Pharmacokinetics and the Absolute Bioavailability of SRT2104 Given as a 250mg Oral Suspension and Intravenous Microdose of 100 µg Carbon-14 Radio-labeled SRT2104 in Healthy Male Subjects

Diabetes Mellitus, Type 2

United Kingdom
Sirtris, a GSK Company
GlaxoSmithKline

Completed

Clinical Study to Assess the Safety and Pharmacokinetics of SRT2104 in Type 2 Diabetic Human Subjects

Diabetes Mellitus, Type 2

Bulgaria, Estonia, Russian Federation, Ukraine, United Kingdom, Hungary, Poland, Romania
GlaxoSmithKline

Completed

Clinical Study to Assess the Pharmacokinetics, Safety and Tolerability of SRT2104 Administered to Normal Healthy Male Volunteers

Diabetes Mellitus, Type 2

United Kingdom
GlaxoSmithKline

Completed

A Clinical Study to Assess the Safety, Tolerability, and Activity of Oral SRT2104 Capsules Administered for 28 Days to Subjects With Type 2 Diabetes Mellitus

Diabetes Mellitus, Type 2

Germany
Sirtris, a GSK Company
GlaxoSmithKline

Completed

Study of the Clinical Activity, Safety, and Tolerability of SRT2104 in Subjects With Moderate to Severe Plaque-Type Psoriasis

Psoriasis

United States
GlaxoSmithKline

Completed

A Clinical Study to Assess the Safety, Tolerability and Pharmacokinetics of Oral SRT2104 Capsules Administered to Healthy Elderly Subjects for 28 Days

Atrophy, Muscular

United Kingdom
Sirtris, a GSK Company
GlaxoSmithKline

Completed

A Clinical Trial to Assess the Safety of Oral SRT2104 and Its Effects on Vascular Dysfunction in Otherwise Healthy Cigarette Smokers and Subjects With Type 2 Diabetes Mellitus

Diabetes Mellitus, Type 2

United Kingdom
Sirtris, a GSK Company
GlaxoSmithKline

Completed

A Clinical Study to Assess the Safety and Pharmacokinetics of SRT2104 in Normal Healthy Male Volunteers

Diabetes Mellitus, Type 2 | Healthy Volunteer

United Kingdom
GlaxoSmithKline

Withdrawn

A Clinical Study to Assess the Effects of SRT2104 Upon Immobilization-Induced Skeletal Muscle Atrophy in Healthy Human Volunteers

Healthy Volunteer | Atrophy, Muscular
Sirtris, a GSK Company
GlaxoSmithKline

Completed

A Phase 1b Study to Assess the Safety and Anti-inflammatory Effects of Two Different Doses of SRT2104 in Patients With Ulcerative Colitis

Colitis, Ulcerative

United States
Seoul National University Hospital

Unknown

Mannitol Brain Relaxation Effect (MANNITOL)

Supratentorial Neoplasms

Korea, Republic of
Endo Pharmaceuticals

Completed

AA4500 for the Treatment of Adhesive Capsulitis of the Shoulder

Adhesive Capsulitis | Frozen Shoulder

United States
Chong Kun Dang Pharmaceutical

Completed

A Clinical Study to Compare the Pharmacokinetic Characteristics of CKD-395 0.5/1000 mg in Healthy Male Volunteers

Diabetes Mellitus, Type II

Korea, Republic of
Hanyang University Seoul Hospital

Completed

The Manikin Study of Chest Compression With One Accelerometer Feedback Device

Cardiac Arrest

Korea, Republic of
Chong Kun Dang Pharmaceutical

Recruiting

Efficacy and Safety of CKD-501 Added to D150 Plus D745 25mg Therapy in Patients With Type 2 Diabetes

Type2 Diabetes

Korea, Republic of
Chong Kun Dang Pharmaceutical

Completed

Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-393 in Healthy Subjects

Diabetes Mellitus, Type 2

Korea, Republic of
Seoul National University Bundang Hospital

Recruiting

Comparison of Dapagliflozin, Lobeglitazone, and Its Combination in Efficacy and Safety (Location-F)

Diabetes Type 2

Korea, Republic of
GlaxoSmithKline

Completed

Effect of Dentifrice Usage Regime on Delivery and Efficacy of Fluoride

Dental Caries

United States
Allecra
Medpace, Inc.

Completed

Cefepime/AAI101 Phase 2 Study in Hospitalized Adults With cUTI

Urinary Tract Infections

Hungary, Czechia, Poland, Slovakia, Ukraine
GE Healthcare

Completed

Safety and Pharmacokinetics of GEH200486 in Healthy Volunteers

Pharmacokinetics

Norway
Dr. Christoph Ilies

Completed

Ultrasound Guided Intercostobrachial Nerve Block

Anaesthesia

Germany
Chong Kun Dang Pharmaceutical

Completed

Retrospective Study to Evaluate the Safety of Duvie in Korean Patients With Type 2 Diabetes Mellitus (DISCOVERY)

Type2 Diabetes

Korea, Republic of
Manhattan Medical Research Practice, PLLC
Endo Pharmaceuticals

Unknown

Additional Xiaflex® Treatment in Patients With Peyronie's Disease Recurrence, Worsening, or Incomplete Response

Peyronie's Disease

United States
Chengdu Kanghong Biotech Co., Ltd.

Unknown

Phase IV Clinical Trial (STAR Study) Extension Study of Conbercept Ophthalmic Injection for Treatment of Polypoid Choroidal Vasculopathy

Polypoid Choroidal Vasculopathy (PCV)

China
Seoul St. Mary's Hospital

Unknown

Study of Evaluation of Cavir Tab. 0.5mg With Food Effect on Pharmacokinetics and Safety

Healthy
Chong Kun Dang Pharmaceutical

Unknown

The Efficacy and Safety of CKD-501 Added to D150 Plus D759 Therapy in Patients With Type 2 Diabetes

Type2 Diabetes

Korea, Republic of
Chong Kun Dang Pharmaceutical

Unknown

Active Drug Comparative Trial to Evaluate the Antiviral Activity and Safety in Chronic Hepatitis B Patients

Hepatitis B, Chronic

Korea, Republic of
Pharmbio Korea Co., Ltd.

Recruiting

Study of PBK_L1704 for the Treatment of Moderate to Severe Acute Pain After Bunionectomy in South Korea

Acute Pain

Korea, Republic of
Chong Kun Dang Pharmaceutical

Completed

Efficacy and Safety of CKD-501 Added to D150 Plus D745 10mg Therapy in Patients With Type 2 Diabetes

Type2 Diabetes

Korea, Republic of
Tongji Hospital

Unknown

Treatment of Calculous Pyonephrosis With 0.5% Iodophors for I-stage PCNL

Urolithiasis

China
RSP Systems A/S

Completed

A Study of a Non-invasive Glucose Measuring Device in Out-patient Settings

Diabetes Mellitus

Germany
RSP Systems A/S

Completed

Study of a Non-invasive Glucose Measuring Device

Diabetes Mellitus

Germany
RSP Systems A/S

Completed

Study of a Novel Non-invasive Glucose Monitoring Device

Diabetes Mellitus

Denmark
Yung Shin Pharm. Ind. Co., Ltd.
Taichung Veterans General Hospital

Completed

Pharmacokinetics of Two Formulations of Entecavir

Hepatitis B
Novartis Pharmaceuticals

Completed

Efficacy and Safety of Ranibizumab 0.5 vs Verteporfin PDT in Patients With Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia (Brilliance)

Visual Impairment Due to Choroidal Neovascularization (CNV) Secondary to Pathologic Myopia (PM)

China, India, Thailand, Hong Kong, Korea, Republic of, Philippines
RSP Systems A/S
Institut für Diabetes-Technologie Forschungs- und Entwicklungsgesellschaft...

Completed

Performance and Safety Evaluation of a Novel Non-invasive Glucose Monitoring Device and Evaluation of the Instructions for Use

Diabetes Mellitus

Germany
HK inno.N Corporation

Completed

Bioequivalence and Safety Study of IN-A012 and Akynzeo Capsules in Male and Female Healthy Korean Subjects

Healthy

Korea, Republic of
Singapore National Eye Centre
Singapore Chung Hwa Medical Institution

Recruiting

Herbal Medication to Treat Dry Eye in Peri/ Post-menopausal Women

Dry Eye

Singapore
Bayer
University of California, San Francisco; Laboratorium für Klinische Forschung; Diagnostic Cytology Laboratory

Completed

Endometrial Safety Study

Postmenopause

Mexico, United States, Italy, Denmark, Austria, Argentina, Brazil, Russian Federation
RSP Systems A/S

Withdrawn

Performance and Safety Evaluation of a Novel Non-invasive Glucose Monitoring Device

Diabetes Mellitus

Denmark, Germany, Sweden, United Kingdom
Andrew J. Armstrong, MD

Completed

The CATCH Prostate Cancer Trial: Cabazitaxel And Tasquinimod in Men With Prostate Cancer (CATCH)

Prostate Cancer

United States
Vaxcyte, Inc.

Active, not recruiting

Safety, Tolerability, and Immunogenicity of a 24-Valent Pneumococcal Conjugate Vaccine (VAX-24) in Healthy Infants

Pneumococcal Vaccines

United States
Shenzhen Fifth People's Hospital

Recruiting

An Evaluation Trial About Anti-claudin18.2 the Specificity of Chimeric Antigen Receptor T Cells in the Advanced Gastric / Esophagogastric Junction Adenocarcinoma and Pancreatic Cancer Subjects

CAR T-Cell Therapy

China
St. Justine's Hospital
Rennes University Hospital

Completed

Cardio-respiratory Events and Inflammatory Response After Primary Immunization in Preterm Infants

Complication Due to Immunization
Chong Kun Dang Pharmaceutical

Completed

CKD-396 Drug-drug Interaction Study(A) (CKD-396 DDI(A) P1)

Diabetes Mellitus, Type II

Korea, Republic of
Novo Nordisk A/S

Completed

A Trial to Assess the Pharmacokinetics, Safety and Tolerability of Semaglutide in Healthy Chinese Subjects

Diabetes Mellitus, Type 2 | Diabetes

China

3

Subscribe